Aging modifies the effect of GCH1 RS11158026 on DAT uptake and Parkinson's disease clinical severity
- 1 February 2017
- journal article
- research article
- Published by Elsevier in Neurobiology of Aging
- Vol. 50, 39-46
Abstract
No abstract availableKeywords
Funding Information
- Michael J. Fox Foundation for Parkinson's Research
This publication has 39 references indexed in Scilit:
- Insulin Resistance, Brain Atrophy, and Cognitive Performance in Late Middle–Aged AdultsDiabetes Care, 2013
- The monoamine neurotransmitter disorders: an expanding range of neurological syndromesThe Lancet Neurology, 2011
- Dopamine promotes formation and secretion of non-fibrillar alpha-synuclein oligomersExperimental & Molecular Medicine, 2011
- GCH1 Haplotype Determines Vascular and Plasma Biopterin Availability in Coronary Artery DiseaseJACC, 2008
- Complex I deficiency in Parkinson's disease frontal cortexBrain Research, 2008
- Early initiation of L-dopa therapy enables stable development of executive function in tetrahydrobiopterin (BH4) deficiencyDevelopmental Medicine & Child Neurology, 2007
- Normative Symbol Digit Modalities Test performance in a community-based sampleArchives of Clinical Neuropsychology, 2006
- Alpha-synuclein and neurodegenerative diseasesNature Reviews Neuroscience, 2001
- Biochemical and fluorodopa positron emission tomographic findings in an asymptomatic carrier of the gene for dopa‐responsive dystoniaAnnals of Neurology, 1994
- Parallel Organization of Functionally Segregated Circuits Linking Basal Ganglia and CortexAnnual Review of Neuroscience, 1986